Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK InhibitionOlga K. Mirzoeva, W. Michael Korn, Debopriya Das et al.|Cancer Research|2009Cited by 390
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Kornélia Polyák, Natalie L. Kingston et al.|JCI Insight|2021Cited by 42